BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20870635)

  • 21. Skin cancer healthcare impact: A nation-wide assessment of an administrative database.
    Duarte AF; Sousa-Pinto B; Freitas A; Delgado L; Costa-Pereira A; Correia O
    Cancer Epidemiol; 2018 Oct; 56():154-160. PubMed ID: 30179829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical treatment of basal cell carcinoma and squamous cell carcinoma.
    Gualdi G; Monari P; Apalla Z; Lallas A
    G Ital Dermatol Venereol; 2015 Aug; 150(4):435-47. PubMed ID: 26140396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost comparisons of managing complex facial basal cell carcinoma: Canadian study.
    Lear W; Mittmann N; Barnes E; Breen D; Murray C
    J Cutan Med Surg; 2008; 12(2):82-7. PubMed ID: 18346405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic impact of preoperative curettage before Mohs micrographic surgery for basal cell carcinoma.
    Lee DA; Ratner D
    Dermatol Surg; 2006 Jul; 32(7):916-22; discussion 922-3. PubMed ID: 16875474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of nonmelanoma skin cancer in 2007.
    Neville JA; Welch E; Leffell DJ
    Nat Clin Pract Oncol; 2007 Aug; 4(8):462-9. PubMed ID: 17657251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery.
    Erickson C; Miller SJ
    Int J Dermatol; 2010 May; 49(5):482-91. PubMed ID: 20534080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
    Newlands C; Currie R; Memon A; Whitaker S; Woolford T
    J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost analysis studies of Mohs micrographic surgery.
    Weber WN
    J Am Acad Dermatol; 1999 Jul; 41(1):130-1. PubMed ID: 10411428
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonmelanoma skin cancer treatment training varies across different medical specialists.
    Romero PC; Kinney MA; Taylor SL; Levender MM; David LR; Goldman ND; Khanna VC; Williford PM; Feldman SR
    J Dermatolog Treat; 2013 Jun; 24(3):215-20. PubMed ID: 22385124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nationwide hospitalization costs of skin melanoma and non-melanoma skin cancer in Germany.
    Stang A; Stausberg J; Boedeker W; Kerek-Bodden H; Jöckel KH
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):65-72. PubMed ID: 18181975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare.
    Joseph AK; Mark TL; Mueller C
    Dermatol Surg; 2001 Nov; 27(11):955-9. PubMed ID: 11737130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inpatient management of patients with skin cancer in Germany: an analysis of the nationwide DRG-statistic 2005-2006.
    Stang A; Stausberg J
    Br J Dermatol; 2009 Nov; 161 Suppl 3():99-106. PubMed ID: 19775365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician.
    Martinez JC; Otley CC
    Mayo Clin Proc; 2001 Dec; 76(12):1253-65. PubMed ID: 11761506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy of basal cell carcinoma: evolving approaches.
    Gaspari AA; Sauder DN
    Dermatol Surg; 2003 Oct; 29(10):1027-34. PubMed ID: 12974699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-melanoma skin cancers in New Zealand--a neglected problem.
    Brougham ND; Dennett ER; Tan ST
    N Z Med J; 2010 Nov; 123(1325):59-65. PubMed ID: 21317962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consensus for Nonmelanoma Skin Cancer Treatment, Part II: Squamous Cell Carcinoma, Including a Cost Analysis of Treatment Methods.
    Kauvar AN; Arpey CJ; Hruza G; Olbricht SM; Bennett R; Mahmoud BH
    Dermatol Surg; 2015 Nov; 41(11):1214-40. PubMed ID: 26445288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of non-melanoma skin cancer.
    Lazareth V
    Semin Oncol Nurs; 2013 Aug; 29(3):182-94. PubMed ID: 23958216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population.
    Viola KV; Jhaveri MB; Soulos PR; Turner RB; Tolpinrud WL; Doshi D; Gross CP
    Arch Dermatol; 2012 Apr; 148(4):473-7. PubMed ID: 22508870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods.
    Kauvar AN; Cronin T; Roenigk R; Hruza G; Bennett R;
    Dermatol Surg; 2015 May; 41(5):550-71. PubMed ID: 25868035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mohs Micrographic Surgery: Past, Present, and Future.
    Cohen DK; Goldberg DJ
    Dermatol Surg; 2019 Mar; 45(3):329-339. PubMed ID: 30608296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.